Elevated alanine aminotransferase levels are associated with impaired fasting glucose and type 2 diabetes in obese women

2012, Número 6

Ann Hepatol 2012; 11 (6)

Rodríguez-Hernández H, Simental-Mendía LE, Bermúdez-Peña C, Zambrano-Galván G, Rodríguez-Morán M, Guerrero-Romero F

Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 3
Paginas: 966
Archivo PDF: 49.67 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

Sattar N, Scherbakova O, Ford I, O’Reilly D, Stanley A, Forrest E, Mc Farlane P. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 2004; 53: 2855-60.
Wannamethee SG, Lennon L, Shaper AG, Whincup PH. Hepatic enzymes, the metabolic syndrome and the risk of type 2 diabetes in older. Diabetes Care 2005; 28: 2913-18.
Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino RB Jr, Haffner SM. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 2005; 54: 3140-47.